15 NGOs call for a clearer definition of the term “nanomaterials”

.
.
.
Newsflash
definition regulation

Fifteen NGOs have sent an open letter to the European Commission asking it to clarify and improve its definition of the term “nanomaterials”.

After seven years of delay and procrastination, the European Commission hastily launched a so-called “consultation” last May-June, which proposes unclear changes and, worse, is likely to make a large number of manufactured nanoparticles disappear from the authorities’ radar.

While the registration of nanomaterials in REACH is already deficient (there are half as many nanomaterials registered in REACH as there are in the French r-nano register) and their labeling is mostly unenforced, this setback in the monitoring of nanomaterials is particularly worrying.

The NGOs would therefore like the Commission to open the discussion so that this definition can be reworked collectively before being integrated into the various European regulations.

Upcoming Nano Agenda

27
Jan.
2026
Nanotechnologies and agriculture: a reference framework for responsible practice (AFNOR, online)
On line
Webinar
agriculture
pesticides
standardization
  • Webconference for analysis laboratories, plant fertilizer manufacturers and distributors, public authorities…
  • Moderated by David Krupka, nanotechnologies development manager at AFNOR Normalisation and Emilie Langlois-Bertrand, nantechnologies standardization project manager.
  • In partnership with Armand Masion, CNRS Research Director, and Sandrine Mocoeur, Health, Safety, Environment and Quality Manager at SYNGENTA.
  • This exchange will also be an opportunity to explore the creation of a national platform to identify standardization needs.
  • Website: www.afnor.org/evenement/nanotechnologies-agriculture-cadre-pratique-responsable/

2
Juin
2026
Emerging pathologies and risks (CNMST 2026, Lyon – France)
Lyon
Congress
health
health
occupational health
prevention
risks
  • 8th Congress of Occupational Medicine and Health (CNMST 2026)
  • Theme 5: Emerging pathologies and risks, Mr Henri Bastos (ANSES), Pr Lynda Bensefa-Colas (AP-HP), Dr Catherine Nisse (CHU Lille)
  • Website: www.medecine-sante-travail.com
26
Juin
2026
Nanomaterials and Health (ANSES, Maisons-Alfort)
Maisons-Alfort
Dialogue Committee